Heritage Wealth Management (Arizona)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$349K Sell
1,690
-177
-9% -$40.1K 0.19% 102
2024
Q1
$506K Sell
1,867
-43
-2% -$10.3K 0.26% 83
2023
Q4
$452K Buy
+1,910
New +$376K 0.24% 87
2022
Q4
$1.24M Buy
5,710
+3,419
+149% +$747K 0.18% 95
2022
Q3
$451K Sell
2,291
-226
-9% -$48.8K 0.14% 108
2022
Q2
$539K Buy
2,517
+236
+10% +$57.7K 0.18% 92
2022
Q1
$648K Buy
+2,281
New +$703K 0.18% 96
2021
Q3
$374K Buy
906
+130
+17% +$54K 0.13% 121
2021
Q2
$287K Buy
776
+364
+88% +$122K 0.11% 159
2021
Q1
$119K Buy
+412
New +$115K 0.07% 227

Other funds holding CRL

Heritage Wealth Management (Arizona)'s CRL Position: Q2 2024 in Review

Heritage Wealth Management (Arizona) reduced its Charles River Laboratories (CRL) stake by 9.5% in Q2 2024, selling an estimated $40.1K and leaving 1,690 shares worth $349K. The position accounts for 0.19% of the portfolio, ranked #102.

Heritage Wealth Management (Arizona) first reported a position in CRL in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.24M in Q4 2022. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Heritage Wealth Management (Arizona) held 1,690 shares of Charles River Laboratories worth $349K as of Q2 2024.
  • Heritage Wealth Management (Arizona) sold 177 Charles River Laboratories shares in Q2 2024, an estimated $40.1K.
  • Charles River Laboratories made up 0.19% of Heritage Wealth Management (Arizona)'s portfolio in Q2 2024, its #102 holding.
  • Heritage Wealth Management (Arizona) first reported a position in Charles River Laboratories in Q1 2021 and has held it in 10 quarters since.
  • Heritage Wealth Management (Arizona)'s Charles River Laboratories position peaked at $1.24M in Q4 2022.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q2 2024, filed 30 Jul 2024.